Clinical Trials in Philadelphia

Showing 20421-20440 of 20,904 trials

Phase I, Open Label, Single Center Safety Study of [F-18]FLT

NCT00553748

This is a ten subject, phase 1 study. The purpose of the Phase 1 study is to demonstrate drug safety in a target group of subjects with high grade brain cancer. This population represents a potential clinical population that may benefit from this PET imaging tracer. The study will also begin collection of baseline imaging data and allow us to gain information to improve design and conduct of future trials.

Brain Cancer

Siemens Molecular Imaging11 participantsStarted Nov 2007

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention

NCT00133731

The objective of this dose-ranging study is to determine the effects of several intravenous (IV) regimens of otamixaban on pharmacodynamic markers (including markers of thrombosis and coagulation markers), safety/tolerability, clinical efficacy and pharmacokinetics.

Angioplasty, Transluminal, Percutaneous Coronary

Sanofi947 participantsStarted Sep 2004

Los Angeles, California, United States • Santa Ana, California, United States • Washington D.C., District of Columbia, United States +86 more locations

Phase I, Open Label, Single Center Safety Study of [F-18]FLT

The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention

Find Trials by Condition in Philadelphia

High Intensity Focused Ultrasound (HIFU) Ablation System Study

Effectiveness of Bracing in Preventing Scoliosis in Children With Spinal Cord Injury

Clinical Trial in Males With BPH (Enlarged Prostate)

Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder

Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease

Mechanism of Thrombocytopenia in Infants

Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy

Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction

A Study to Determine the Effectiveness of Endoscopic Full-Thickness Plication for the Treatment of GERD

Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

Tolerance of Healthy, Term Infants to Infant Formulas

Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males

An Observational Study of Pruritus Amongst Hemodialysis Patients